All Commentary
Wednesday, November 22, 2006

FDA Faces New Hearing on Life-Saving Drugs


A federal court agreed yesterday to rehear a case that aims to get terminally ill patients early access to experimental drugs unlikely to be approved before they die. (Washington Post, Wednesday)

Does this really require comment?

FEE Timely Classic
The FDA Cannot Be Reformed (pdf) by Arthur E. Foulkes